ADS-ADEA 2016* Clinical Science
Chairs: Dorit Samocha-Bonet & Trisha O'Moore-Sullivan
Reduction in the risk of developing type 2 diabetes (T2D) with liraglutide 3.0 mg in people with prediabetes from the SCALE Obesity and Prediabetes randomised, double-blind, placebo-controlled trial (#178)
11:30 AM
The 5:2 STOP Study: A pilot study to compare the metabolic effects and safety of weight loss via intermittent fasting versus standard continuous energy restriction in patients with Type 1 diabetes and overweight or obesity (#179)
11:45 AM
Higher glomerular filtration rate is related to insulin resistance independently of obesity in healthy non-diabetic adults (#180)
12:00 PM
Evaluating the Obesity Paradox in Type 2 Diabetes with Real-world Data from Primary Care System (#181)
12:15 PM
Insulin-sensitive overweight/obese adults remain as insulin-sensitive as lean subjects over 6 years (#182)
12:30 PM
Five-year outcomes of a randomized trial of gastric band surgery in overweight but not obese people with type 2 diabetes (#183)
12:45 PM